CARLSBAD, Calif.–(BUSINESS WIRE)–Arima Genomics, Inc., a cancer diagnostics company bringing DNA sequence and structure together to advance cancer therapy selection, today announced a distribution partnership with Active Motif Incorporated, a leading provider of epigenetics and multiomic solutions to mechanistic, translational, and clinical researchers, under which Active Motif will be granted exclusive distribution rights to Arima’s Hi-C kits and services for research applications. Under the
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
